193 related articles for article (PubMed ID: 16328437)
1. Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population.
Jiang J; Wang J; Suzuki S; Gajalakshmi V; Kuriki K; Zhao Y; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
J Cancer Res Clin Oncol; 2006 Mar; 132(3):193-9. PubMed ID: 16328437
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
Forones NM; de Lima JM; de Souza LG; da Silva ID
J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
[TBL] [Abstract][Full Text] [Related]
3. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population.
Liu W; Zhu E; Wang R; Wang L; Gao L; Yang X; Liu T
Cancer Epidemiol; 2011 Aug; 35(4):e12-7. PubMed ID: 21185249
[TBL] [Abstract][Full Text] [Related]
5. Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer.
Le Marchand L; Seifried A; Lum-Jones A; Donlon T; Wilkens LR
JAMA; 2003 Dec; 290(21):2843-8. PubMed ID: 14657069
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.
Schernhammer ES; Tranah GJ; Giovannucci E; Chan AT; Ma J; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
Br J Cancer; 2006 Mar; 94(6):928-34. PubMed ID: 16495921
[TBL] [Abstract][Full Text] [Related]
8. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
Zhang W; Gordon M; Press OA; Rhodes K; Vallböhmer D; Yang DY; Park D; Fazzone W; Schultheis A; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
Pharmacogenet Genomics; 2006 Jul; 16(7):475-83. PubMed ID: 16788380
[TBL] [Abstract][Full Text] [Related]
10. The significant association of CCND1 genotypes with colorectal cancer in Taiwan.
Huang CY; Tsai CW; Hsu CM; Chang WS; Shui HA; Bau DT
Tumour Biol; 2015 Aug; 36(8):6533-40. PubMed ID: 25809706
[TBL] [Abstract][Full Text] [Related]
11. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
Xie M; Zhao F; Zou X; Jin S; Xiong S
Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
[TBL] [Abstract][Full Text] [Related]
12. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
13. Single Nucleotide Polymorphism (A870G) of the
Montazer Haghighi M; Vahedi M; Nazemolhosseini Mojarad E
Gastroenterol Hepatol Bed Bench; 2017; 10(Suppl1):S48-S53. PubMed ID: 29511472
[TBL] [Abstract][Full Text] [Related]
14. [Impact of CCND1 A870G polymorphism on acute adverse events in postoperative rectal cancer patients treated with adjuvant concurrent chemoradiotherapy].
Qiao Y; Ren H; Huang Y; DU ZL; Yu DK; Jin J; Li YX; Lin DX; Tan W
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):268-72. PubMed ID: 23985254
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 G870A polymorphism and risk of colorectal cancer: a case control study.
Sameer AS; Parray FQ; Dar MA; Nissar S; Banday MZ; Rasool S; Gulzar GM; Chowdri NA; Siddiqi MA
Mol Med Rep; 2013 Mar; 7(3):811-5. PubMed ID: 23354584
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
[TBL] [Abstract][Full Text] [Related]
17. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study.
Probst-Hensch NM; Sun CL; Van Den Berg D; Ceschi M; Koh WP; Yu MC
Carcinogenesis; 2006 Dec; 27(12):2475-82. PubMed ID: 16829689
[TBL] [Abstract][Full Text] [Related]
18. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT
Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638
[TBL] [Abstract][Full Text] [Related]
19. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
[TBL] [Abstract][Full Text] [Related]
20. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]